Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

NCT06311227 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

NIH

Sponsor class

Conditions

Recurrent Hairy Cell Leukemia
Recurrent Hairy Cell Leukemia Variant

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
DRUG: Venetoclax

Sponsor

National Cancer Institute (NCI)